Back to Blog

Supplements for Ovarian Cysts: Hormonal Balance Support

February 27, 2026·5 min read

Ovarian cysts are fluid-filled sacs that develop on or within the ovaries and are extremely common — most women develop them at some point during their reproductive years. The majority are functional cysts that form as part of normal ovulation and resolve on their own within one to three menstrual cycles. However, persistent cysts, endometriomas, and cysts associated with PCOS warrant targeted management. Supplements that support hormonal balance, reduce inflammation, and improve ovarian function may complement conventional monitoring and treatment.

Understanding Cyst Types and Supplement Relevance

Functional cysts (follicular cysts and corpus luteum cysts) result from normal ovulatory processes that do not complete correctly. They are estrogen-influenced and typically resolve without intervention. Endometriomas are endometriosis-related cysts containing old blood and are addressed separately. PCOS-associated cysts are not true cysts but undeveloped follicles arrested by hormonal imbalance. The supplements discussed here are most relevant to functional cysts and PCOS-associated cysts.

Inositol: FSH Signaling and Follicle Development

Myo-inositol is the most evidence-supported supplement for ovarian cyst management in the context of PCOS. By restoring FSH receptor sensitivity, myo-inositol supports normal follicular development and ovulation, reducing the accumulation of arrested follicles characteristic of PCOS ovaries.

A 2011 study in Gynecological Endocrinology found that myo-inositol supplementation at 4 g per day significantly reduced the number of ovarian cysts and improved menstrual regularity in women with PCOS. The 40:1 ratio of myo-inositol to D-chiro-inositol is the evidence-supported combination for PCOS management, taken in two divided doses of 2 g myo-inositol each.

Vitex (Chasteberry): Dopamine, Prolactin, and LH Modulation

Vitex agnus-castus (chasteberry) acts on dopamine D2 receptors in the pituitary gland, suppressing prolactin secretion and normalizing LH release. Elevated LH relative to FSH is a hallmark of PCOS and contributes to both anovulation and functional cyst formation. Elevated prolactin from any cause can also prevent ovulation and promote cyst persistence.

Standardized chasteberry extract at 20 to 40 mg per day has been shown in clinical trials to normalize prolactin and LH, restore ovulation, and improve luteal phase function. It is most appropriate for women with identifiable LH excess or hyperprolactinemia and less useful for women with normal LH and prolactin. Effects typically take two to three menstrual cycles to become apparent.

Vitamin D: Follicular Environment and Insulin Sensitivity

Vitamin D receptors are expressed in granulosa cells, theca cells, and the oocyte itself. Vitamin D influences follicle maturation, granulosa cell function, and anti-Mullerian hormone production. Women with PCOS have significantly higher rates of vitamin D deficiency than healthy controls, and deficiency correlates with more severe insulin resistance and higher androgen levels.

Correcting vitamin D deficiency to 40 to 60 ng/mL through supplementation with 2,000 to 4,000 IU of vitamin D3 daily improves insulin sensitivity, reduces androgen levels, and supports more orderly follicular development — all factors that reduce the hormonal environment conducive to persistent cysts.

NAC: Antioxidant Support and Insulin Sensitization

NAC's evidence in ovarian cysts is most established through the 2013 endometrioma RCT, but its insulin-sensitizing and antioxidant properties are relevant to functional cysts and PCOS-related cysts as well. NAC has been studied alongside clomiphene in PCOS patients with superior ovulation induction rates compared to clomiphene alone, suggesting it positively influences ovarian follicular dynamics.

At 600 mg twice daily, NAC provides glutathione support in the ovarian microenvironment and has mild insulin-sensitizing properties that complement inositol in the PCOS context.

Omega-3 Fatty Acids: Androgen and Inflammation Reduction

Several studies have found that omega-3 supplementation reduces testosterone and LH levels in women with PCOS while improving insulin sensitivity. A 2012 RCT found that 3 g per day of omega-3 supplementation for eight weeks significantly reduced testosterone and improved menstrual regularity in PCOS patients.

The anti-inflammatory effects of omega-3 reduce the chronic low-grade inflammation that characterizes PCOS and may contribute to the follicular arrest underlying ovarian cysts. One to two grams of combined EPA/DHA daily is appropriate.

FAQ

Q: Can these supplements prevent functional cysts from forming?

Supplements that support normal ovulation (inositol, vitex, vitamin D) may reduce the frequency of follicular cysts that form when ovulation is incomplete. They cannot prevent all functional cysts, which are part of normal ovarian cycling.

Q: How long should I take these supplements?

For PCOS-related cysts, ongoing supplementation provides sustained hormonal support. Reassess with ultrasound every three to six months to monitor progress.

Q: Should I avoid these supplements if I have an endometrioma?

Endometriomas have different drivers than functional cysts. The NAC evidence is specifically relevant to endometriomas. Inositol and vitex are less directly applicable but not contraindicated.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free